BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20032638)

  • 1. Oncogene-induced cellular senescence.
    Chandeck C; Mooi WJ
    Adv Anat Pathol; 2010 Jan; 17(1):42-8. PubMed ID: 20032638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?
    Felsher DW
    Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene-induced cellular senescence: causal factor in the growth arrest of pituitary microadenomas?
    Mooi WJ
    Horm Res; 2009 Apr; 71 Suppl 2():78-81. PubMed ID: 19407502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular senescence in vivo: a barrier to tumorigenesis.
    Prieur A; Peeper DS
    Curr Opin Cell Biol; 2008 Apr; 20(2):150-5. PubMed ID: 18353625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene-induced senescence: the bright and dark side of the response.
    Gorgoulis VG; Halazonetis TD
    Curr Opin Cell Biol; 2010 Dec; 22(6):816-27. PubMed ID: 20807678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.
    Di Micco R; Fumagalli M; Cicalese A; Piccinin S; Gasparini P; Luise C; Schurra C; Garre' M; Nuciforo PG; Bensimon A; Maestro R; Pelicci PG; d'Adda di Fagagna F
    Nature; 2006 Nov; 444(7119):638-42. PubMed ID: 17136094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence.
    Leikam C; Hufnagel A; Schartl M; Meierjohann S
    Oncogene; 2008 Nov; 27(56):7070-82. PubMed ID: 18806824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallmarks for senescence in carcinogenesis: novel signaling players.
    Caino MC; Meshki J; Kazanietz MG
    Apoptosis; 2009 Apr; 14(4):392-408. PubMed ID: 19169823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence.
    Larsson LG
    Semin Cancer Biol; 2011 Dec; 21(6):367-76. PubMed ID: 22037160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene-induced senescence as an initial barrier in lymphoma development.
    Braig M; Lee S; Loddenkemper C; Rudolph C; Peters AH; Schlegelberger B; Stein H; Dörken B; Jenuwein T; Schmitt CA
    Nature; 2005 Aug; 436(7051):660-5. PubMed ID: 16079837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Many roads lead to oncogene-induced senescence.
    Courtois-Cox S; Jones SL; Cichowski K
    Oncogene; 2008 May; 27(20):2801-9. PubMed ID: 18193093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escape from premature senescence is not sufficient for oncogenic transformation by Ras.
    Peeper DS; Dannenberg JH; Douma S; te Riele H; Bernards R
    Nat Cell Biol; 2001 Feb; 3(2):198-203. PubMed ID: 11175753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.
    Bartkova J; Rezaei N; Liontos M; Karakaidos P; Kletsas D; Issaeva N; Vassiliou LV; Kolettas E; Niforou K; Zoumpourlis VC; Takaoka M; Nakagawa H; Tort F; Fugger K; Johansson F; Sehested M; Andersen CL; Dyrskjot L; Ørntoft T; Lukas J; Kittas C; Helleday T; Halazonetis TD; Bartek J; Gorgoulis VG
    Nature; 2006 Nov; 444(7119):633-7. PubMed ID: 17136093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular senescence: hot or what?
    Evan GI; d'Adda di Fagagna F
    Curr Opin Genet Dev; 2009 Feb; 19(1):25-31. PubMed ID: 19181515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA; Poon RY
    Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells.
    Chi S; Kitanaka C; Noguchi K; Mochizuki T; Nagashima Y; Shirouzu M; Fujita H; Yoshida M; Chen W; Asai A; Himeno M; Yokoyama S; Kuchino Y
    Oncogene; 1999 Apr; 18(13):2281-90. PubMed ID: 10327074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal cellular senescence and cancer susceptibility in mice genetically deficient in Ras-induced senescence-1 (Ris1).
    Nieto M; Barradas M; Criado LM; Flores JM; Serrano M; Llano E
    Oncogene; 2007 Mar; 26(12):1673-80. PubMed ID: 16964279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jailbreak: oncogene-induced senescence and its evasion.
    McDuff FK; Turner SD
    Cell Signal; 2011 Jan; 23(1):6-13. PubMed ID: 20633638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual role of TMS1/ASC in death receptor signaling.
    Parsons MJ; Vertino PM
    Oncogene; 2006 Nov; 25(52):6948-58. PubMed ID: 16715133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.